The role of specialized cell cycles during erythroid lineage development: insights from single-cell RNA sequencing
Authors
Socolovsky, MeravUMass Chan Affiliations
Molecular, Cell and Cancer BiologyDocument Type
Journal ArticlePublication Date
2022-06-27Keywords
CDK inhibitorsCell cycle
Erythropoiesis
Erythropoietic stress response
Glucocorticoids
Replication forks
Metadata
Show full item recordAbstract
Early erythroid progenitors known as CFU-e undergo multiple self-renewal cell cycles. The CFU-e developmental stage ends with the onset of erythroid terminal differentiation (ETD). The transition from CFU-e to ETD is a critical cell fate decision that determines erythropoietic rate. Here we review recent insights into the regulation of this transition, garnered from flow cytometric and single-cell RNA sequencing studies. We find that the CFU-e/ETD transition is a rapid S phase-dependent transcriptional switch. It takes place during an S phase that is much shorter than in preceding or subsequent cycles, as a result of globally faster replication forks. Furthermore, it is preceded by cycles in which G1 becomes gradually shorter. These dramatic cell cycle and S phase remodeling events are directly linked to regulation of the CFU-e/ETD switch. Moreover, regulators of erythropoietic rate exert their effects by modulating cell cycle duration and S phase speed. Glucocorticoids increase erythropoietic rate by inducing the CDK inhibitor p57KIP2, which slows replication forks, inhibiting the CFU-e/ETD switch. Conversely, erythropoietin promotes induction of ETD by shortening the cycle. S phase shortening was reported during cell fate decisions in non-erythroid lineages, suggesting a fundamentally new developmental role for cell cycle speed.Source
Socolovsky M. The role of specialized cell cycles during erythroid lineage development: insights from single-cell RNA sequencing. Int J Hematol. 2022 Aug;116(2):163-173. doi: 10.1007/s12185-022-03406-9. Epub 2022 Jun 27. PMID: 35759181.DOI
10.1007/s12185-022-03406-9Permanent Link to this Item
http://hdl.handle.net/20.500.14038/51174PubMed ID
35759181Rights
© 2022. Japanese Society of Hematology.ae974a485f413a2113503eed53cd6c53
10.1007/s12185-022-03406-9